UAE – PureHealth has struck an agreement to acquire Circle Health Group, an independent hospital operator based in the United Kingdom, in a deal valued at US$1.2 billion.
Upon closing the proposed billion-dollar deal with Circle Health Group, PureHealth will enter the United Kingdom market for the first time.
This acquisition underlines PureHealth’s commitment to delivering world-class medical care to patients globally.
In a press release, the company said: “PureHealth aims to invest in scientific innovation and healthcare infrastructure within all its assets, including Circle Health Group, to unlock longevity and greater quality of life for humankind.”
As part of the strategic acquisition, PureHealth will gain 100% of Circle Health Group’s network of state-of-the-art hospitals
PureHealth will have full control of the Group’s secondary care service portfolio, covering specialties such as Orthopaedics, Oncology, Cardiothoracic Surgery, Ophthalmology, Neurosurgery, and General Surgery.
Welcoming Circle Health Group into the PureHealth family, Farhan Malik, Managing Director and Group Chief Executive Officer of PureHealth, stated: “This acquisition marks an important milestone in our journey towards creating a global healthcare network that revolutionizes patient care.”
Notably, Centene Corporation first invested in UK-based Circle Health Group in 2019 and acquired its remaining equity in 2021.
Circle Health Group is set to join a roster of world-class healthcare providers that make up PureHealth companies, including PureLab, Rafed, and Abu Dhabi Stem Cells Centre.
With this new acquisition, PureHealth seeks to ensure patients around the world have access to exceptional medical care with the highest international quality standards.
It represents a significant step forward in the company’s strategic objectives aimed at developing new clinical care pathways made up of the best healthcare providers to meet patient needs.
On her part, the Chief Executive Officer of Centene, Sarah London said: “This transaction marks another milestone in our portfolio review and showcases continued momentum against our value creation plan.”
The proposed deal forms part of PureHealth’s global expansion program, which includes acquisitions previously completed in the United States, as well as entry into other international markets.
PureHealth is well-positioned to make significant contributions to the improvement of the UAE’s and the UK’s healthcare ecosystem and deliver world-class medical services in the UAE and beyond.
“Over the years, Circle Health Group has had a significant impact for the benefit of patients across the United Kingdom. We are confident that this business will continue to thrive under the ownership of PureHealth,” underscored Sarah London.
By virtue of this, PureHealth will leverage its industry experience to develop an expanded network of medical professionals and expertise combined with the sharing of knowledge.
Other benefits include the expansion of clinical knowledge and delivery of new medical techniques through enhanced collaboration between medical professionals, the use of cutting-edge technologies, and the provision of broadened treatment options for patients in the UAE.
Remarkably, this buyout deal comes shortly after PureHealth and Fujifilm Global agreed to combine their respective technological capabilities to enhance excellence benchmarks in the healthcare sector in the Emirate of Abu Dhabi and beyond.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
